Pages
-
-
Serum biomarkers in prednisolone-treated hand osteoarthritis patients
-
-
Neuropathic-like pain symptoms in inflammatory hand osteoarthritis lower quality of life and may not decrease under prednisolone treatment
-
-
Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases
-
-
Two-year changes in magnetic resonance imaging features and pain in thumb base osteoarthritis
-
-
Real-time vs static scoring in musculoskeletal ultrasonography in patients with inflammatory hand osteoarthritis
-
-
Reproducibility of targeted lipidome analyses (Lipidyzer) in plasma and erythrocytes over a 6-week period
-
-
Inflammation as a target for treatment in hand osteoarthritis
-
-
Measures of Hand Function
-
-
Percentile curves for the knee injury and osteoarthritis outcome score in the middle-aged Dutch population
-
-
Self-reported painful joint count and assessor-reported tender joint count as instruments to assess pain in hand osteoarthritis
-
-
The role of leptin and adiponectin as mediators in the relationship between adiposity and hand and knee osteoarthritis
-
-
Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trial
-
-
Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trial
-
-
Etanercept therapy leads to reductions in matrix metalloproteinase-3 in patients with erosive hand osteoarthritis
-
-
Report from the Hand Osteoarthritis Working Group at OMERACT 2018: Update on Core Instrument Set Development
-
-
Longitudinal Reliability of the OMERACT Thumb Base Osteoarthritis Magnetic Resonance Imaging Scoring System (TOMS)
-
-
Assessment of osteoarthritic features in the thumb base with the newly developed OMERACT magnetic resonance imaging scoring system is a valid addition to standard radiography
-
-
Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial
-
-
Performance of the Michigan Hand Outcomes Questionnaire in hand osteoarthritis
-
-
TNF inhibitor treatment is associated with a lower risk of hand osteoarthritis progression in rheumatoid arthritis patients after 10 years
-
-
In thumb base osteoarthritis structural damage is more strongly associated with pain than synovitis
-
-
Comparison of histological and morphometrical changes underlying subchondral bone abnormalities in inflammatory and degenerative musculoskeletal disorders: a systematic review
-
-
Efficacy and safety of non-pharmacological, pharmacological and surgical treatment for hand osteoarthritis: a systematic literature review informing the 2018 update of the EULAR recommendations for the management of hand osteoarthritis
-
-
Validity, reliability, responsiveness and feasibility of four hand mobility measures in hand osteoarthritis
Pages